[Photo] SillaJen Corporate Presentation
![[Photo] SillaJen Corporate Presentation](http://www.asiae.co.kr/news/img_view.htm?img=2022121310215349678_1670894513.jpg)
Shinragen, a medical and pharmaceutical research and development company, held a corporate briefing session at the Seoul Press Center on the 13th to discuss the current status of research and development and future plans. Executive Director Park Sang-geun is explaining the clinical status and plans for the next-generation anticancer virus. / Reporter Heo Young-han younghan@
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
